✦ Health Affairs on July 24 issued a series of health policy briefs on issues shaping the prescription drug market and how they affect drug pricing. The first set focuses on pre-launch issues: expedited approval pathways, pricing of orphan drugs, biosimilars and patent settlements. The journal said additional primers will be issued later this summer […]
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.